ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Theriva Biologics Inc

Theriva Biologics Inc (TOVX)

1.46
-0.01
( -0.68% )
Updated: 11:51:46

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -7.33M-5.18M-5.82M-4.22M-6.22M-5.39M-8.49M-7.89M
Pre Tax Income -7.02M-4.81M-5.44M-3.83M-5.91M-5.17M-8.32M-7.73M
Net Income -5.59M-4.48M-5.09M-3.3M-5.49M-5.17M-8.32M-7.73M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.33M-5.18M-5.82M-4.22M-6.22M-5.39M-8.49M-7.89M
EBITDA -7.31M-5.15M-5.79M-4.18M-6.18M-5.35M-4.38M-5M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -39.25M-26.25M-17.57M-15.66M-10.16M-14.27M-21.58M-21.43M
Pre Tax Income -27.8M-15.49M-13.42M-15.38M-10.12M-14.27M-21.11M-19.99M
Net Income -27.26M-22.14M-25.29M-16.08M-12.56M-23.19M-20.03M-18.35M
Preferred Dividends 0-6.96M-11.92M-773k-1.63M-1.52M00
Basic Earnings Per Share (EPS) -0.186-0.14-0.561-0.347-0.213-0.143-0.448-0.391
EBIT -39.25M-26.25M-17.57M-15.66M-10.16M-14.27M-21.58M-21.43M
EBITDA -39.1M-26.01M-17.3M-15.42M-9.96M-14.19M-21.5M-21.3M